Table 3.
The association of FBXO31 with clinicopathological features of 50 patients with lung cancer
| Characteristic | No. of patients | FBXO31 ΔCt | P | |
|---|---|---|---|---|
|
| ||||
| No | % | Mean ± SD | ||
| Age, years | ||||
| >60 | 31 | 62% | 5.356 ± 0.2192 | 0.0661 |
| ≤60 | 19 | 38% | 6.015 ± 0.2407 | |
| Sex | ||||
| Male | 36 | 72% | 5.729 ± 0.2423 | 0.2690 |
| Female | 14 | 28% | 5.346 ± 0.2143 | |
| Size | ||||
| >3 cm | 27 | 54% | 5.255 ± 0.1630 | 0.0035 |
| ≤3 cm | 23 | 46% | 6.284 ± 0.3606 | |
| Histology type | ||||
| Adenocarcinoma | 36 | 72% | 5.640 ± 0.1764 | 0.5331 |
| Squamous cancer | 14 | 28% | 5.400 ± 0.4140 | |
| Histological grade | ||||
| I, II | 28 | 56% | 6.055 ± 0.2352 | 0.0020 |
| III, IV | 22 | 44% | 5.027 ± 0.2164 | |
| Lymph node status | ||||
| No Metastasis | 13 | 26% | 6.900 ± 0.2895 | 0.0026 |
| Metastasis | 37 | 74% | 5.701 ± 0.2428 | |
| Smoking history | ||||
| Smoker | 32 | 64% | 5.147 ± 0.1500 | 0.0002 |
| Nonsmoker | 18 | 36% | 6.433 ± 0.3657 | |